Recent studies suggested that cells express only PD-1+ indeed retain Ag responsiveness in tumors, while only co-expression of PD-1+ and Tim-3+ identifies the most profoundly hypo-functional T-cells [14–16], and the blockade of them rejuvenates tumor-infiltrating CD8+ T-cells function in cancer patients. Here, CD8A is linked to cancer.